The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNIC.L Regulatory News (CNIC)

  • There is currently no data for CNIC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

24 Jul 2023 07:00

RNS Number : 8785G
CentralNic Group PLC
24 July 2023
 

24 July 2023

CentralNic Group plc

 

("CentralNic" or the "Company")

Transaction in Own Shares

 

CentralNic Group plc (AIM: CNIC), the global internet company that derives recurring revenue from privacy-safe, AI based customer journeys that help online consumers make informed choices, announces that on 21 July 2023 it purchased 286,332 ordinary shares of £0.001 each in the Company (the "Repurchased Shares"), pursuant to the share buyback programme (the "Buyback Programme") that was announced on 15 May 2023, as follows (together the "Transaction"):

Date of purchase

21 July 2023

Number of ordinary shares purchased

286,332

Highest price paid per ordinary share

127.6627 pence

Lowest price paid per ordinary share

127.6627 pence

Volume weighted average price paid per ordinary share

127.6627 pence

Total Voting Rights

 

Following the Transaction, the issued share capital of the Company remains unchanged at 288,660,084 and the Company now holds 8,276,174 shares in treasury. The total voting rights in the Company is now 280,383,910 which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, CentralNic under the FCA's Disclosure Guidance and Transparency Rules.

The Company will make further announcements in due course following the completion of any further purchases pursuant to the Buyback Programme.

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 details of the purchase of its own ordinary shares by CentralNic, which were all executed through the Company's broker, Zeus Capital Limited, are set out below:

Schedule of Purchases: 

 

Shares purchased:

CentralNic Group plc (ISIN: GB00BCCW4X83)

Date of purchases:

21 July 2023

Aggregate information:

 

Aggregated Volume

Volume-weighted average price (pence)

Venue

 

286,332

127.6627

London Stock Exchange

Individual transactions:

 

Volume

Price

Time

 

286,332

127.6627 pence

16:42 UK

CentralNic Group plc

 

+44 (0) 203 388 0600

Michael Riedl, Chief Executive Officer

William Green, Chief Financial Officer

Zeus (NOMAD and Joint Broker)

 

Nick Cowles / Jamie Peel / James Edis (Investment Banking)

+44 (0) 161 831 1512

Dominic King (Corporate Broking)

+44 (0) 203 829 5000

Berenberg (Joint Broker)

+44 (0) 203 207 7800

Mark Whitmore / Richard Andrews / Alix Mecklenburg-Solodkoff

SEC Newgate (for Media)

+44 (0) 203 757 6880

Bob Huxford / Alice Cho / Harry Handyside / Tom Carnegie

centralnic@secnewgate.co.uk

About CentralNic Group Plc

 

CentralNic is a leading global internet solutions company that operates in two highly attractive markets: high-growth digital advertising (Online Marketing segment) and domain name management solutions (Online Presence segment). The company's Online Marketing segment creates privacy-safe and AI-generated online consumer journeys that convert general interest online media users into confident high conviction consumers through advertorial and review websites. The Online Presence segment is a critical constituent of the global online presence and productivity tool ecosystem, where CentralNic serves as the primary distribution channel for a wide range of digital products. The company's high-quality earnings come from subscription recurring revenues in the Online Presence segment and revenue share on rolling utility-style contracts in the Online Marketing segment. The Online Marketing market has a long-term average growth rate of +20%, making it an attractive growth market. With a proven business model, scalable technology, and a track record of delivering accretive M&A, CentralNic has become a global consolidator.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSKXLFLXDLZBBL
Date   Source Headline
25th Apr 20237:00 amRNSResult of AGM
24th Apr 20237:01 amRNSBoard Changes
24th Apr 20237:00 amRNSTrading Update
17th Apr 20237:00 amRNSDirectors' Dealings
17th Apr 20237:00 amRNSShare Awards and Exercise of Options
14th Apr 202311:01 amRNSDirectors' Dealings and Holdings in Company
11th Apr 20233:08 pmRNSDirectors' Dealings
5th Apr 20234:13 pmRNSDirectors' Dealings
3rd Apr 20237:00 amRNSDirectors' Dealings
30th Mar 20238:56 amRNSDirectors’ Dealings
27th Mar 20233:26 pmRNSDirectors’ Dealings
27th Mar 20237:00 amRNSAnnual Report, Notice of Q1 Update, AGM & Dividend
22nd Mar 20231:35 pmRNSDirectors’ Dealings
17th Mar 20234:00 pmRNSHolding(s) in Company
17th Mar 20237:00 amRNSDirectors’ Dealings
16th Mar 20237:00 amRNSHolding(s) in Company
14th Mar 20237:00 amRNSDirectors' Dealings
10th Mar 20237:15 amEQSCentralNic (CNIC): Clarifying the narrative
9th Mar 20237:00 amRNSDirectors’ Dealings
6th Mar 20237:00 amRNSDirectors' Dealings
2nd Mar 20237:00 amRNSCentralNic among FT's fastest growing in Europe
27th Feb 20237:00 amRNSUnaudited Preliminary Accounts for Full Year 2022
31st Jan 20237:00 amRNSPartnership Announcement
30th Jan 20237:00 amRNSTrading Update, Board Changes, Notice of Results
25th Jan 20238:08 amRNSDirectors' Dealings
23rd Jan 20237:00 amRNSDirector Dealings
20th Jan 20237:00 amRNSNotification of Major Holdings
20th Jan 20237:00 amRNSDirectors' Dealings
19th Jan 20237:00 amRNSTransaction in Own Shares
17th Jan 20237:00 amRNSDirectors' Dealings
17th Jan 20237:00 amRNSTransaction in Own Shares
16th Jan 20237:00 amRNSTransaction in Own Shares
13th Jan 20237:00 amRNSTransaction in Own Shares
12th Jan 20238:14 amRNSDirectors' Dealings
12th Jan 20237:00 amRNSTransaction in Own Shares
11th Jan 20237:00 amRNSTransaction in Own Shares
10th Jan 20237:00 amRNSTransaction in Own Shares
10th Jan 20237:00 amRNSHolding(s) in Company
9th Jan 20234:17 pmRNSDirectors' Dealings
9th Jan 20237:00 amRNSTransaction in Own Shares
6th Jan 20238:13 amRNSShare Awards and exercise of Options
6th Jan 20237:00 amRNSTransaction in Own Shares
5th Jan 20237:00 amRNSTransaction in Own Shares
4th Jan 20237:00 amRNSTransaction in Own Shares
3rd Jan 20237:00 amRNSTransaction in Own Shares
3rd Jan 20237:00 amRNSDirectors' Dealings
30th Dec 20227:00 amRNSShare Buyback Programme
21st Dec 20226:17 pmRNSDirectors' Dealings
19th Dec 20227:00 amRNSAcquisition Announcement
16th Dec 20225:49 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.